Gutierrez de Pineres V, Tamayo-Torres CS, Ramirez-Cisneros A, Kavelidou M, et al. Effects of liraglutide treatment for 18 days on metabolic parameters, regional
body composition and the myostatin-activin-follistatin-IGF-1 axis: Results from
an exploratory, randomized, placebo-controlled, crossover study. Diabetes Obes Metab 2026;28:1258-1265.
PMID: 41287185
|